Sanofi's plan to list its API spinout in France is a go
Sanofi’s plan to list its API spinoff on the French markets has been approved, and trading will start on May 6, the company confirmed.
Sanofi expects to hold a 30% stake in EUROAPI once the listing is complete. The EUROAPI board of directors unanimously proposed to submit 58% of shares to shareholders, according to the announcement and will be subject to approval at a May 3 shareholders meeting.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.